Cancer Stem Cells Market to Grow at $1.6 Billion by 2025 | Key Industry Players – Thermo Fisher Scientific, Inc.; AbbVie, Inc.; Merck KGaA; Bionomics; and Lonza

September 02 09:32 2019
Cancer Stem Cells Market to Grow at $1.6 Billion by 2025 | Key Industry Players - Thermo Fisher Scientific, Inc.; AbbVie, Inc.; Merck KGaA; Bionomics; and Lonza

Grand View Research, Inc. – Market Research And Consulting.
According to report published by Grand View Research, The global cancer stem cells market size was valued at USD 679.5 million in 2016. The market is expected to expand at a CAGR of 9.98% during the forecast period

The global cancer stem cells market size is expected to reach USD 1.6 billion by 2025, according to a new report by Grand View Research, Inc., expanding at a CAGR of 9.98% during the forecast period. Although stem cell-based cancer treatment is facing regulatory and ethical challenges, the market is growing worldwide. With increasing awareness about these cells, there is steady growth in the R&D for the development of effective and novel treatment methods based on stem cells.

Furthermore, continuous rise has been observed in the number of research studies on cancer stem cells (CSCs) being published. These studies have helped healthcare professionals gain insights into CSCs biology and their signaling pathways. This is expected to create tremendous growth prospects for the market.

Request a Sample Copy of the Global Cancer Stem Cells Market Research Report @

Furthermore, improvements in experimental approaches, in particular, in vitro assay systems have enabled scientists to establish relationship between different cell types in a tumor and their microenvironment. This has led to development of a broad therapeutic portfolio for CSCs and their associated key pathways for restricting growth of the tumor and providing improved clinical outcome.

North America Anti-Cancer Stem Cell Therapeutics Market Size, by Mode of Action (Target CSCs), 2014-2025 (USD Million)

Further key findings from the study suggest: 

  • The anti-CSC therapeutics segment accounted for a significant share owing to increasing R&D activities for the development of novel therapeutics
  • Anti-CSCs therapeutics/agents include agents that target key pathways, surface markers, immuno-evasion & tumor microenvironment, along with nanoparticle-based therapies. As key pathways play a major role in tumor regulation, pathway inhibitors captured the largest share owing to the presence of a broad portfolio of products under pipeline
  • With rising prevalence of bladder cancer, the segment is expected to exhibit the highest CAGR of 10.47% during the forecast period
  • North America held the largest share in 2016 owing to presence of a large number of facilities in the U.S. that offer stem cell services
  • Asia Pacific is likely to emerge as the fastest growing regional market owing to increasing investments by various agencies to accelerate research activities in Asian countries
  • Some of the prominent players in the market are Thermo Fisher Scientific, Inc.; AbbVie, Inc.; Merck KGaA; Bionomics; and Lonza.

Global Cancer Stem Cells Market Share, by Cancer Forms, 2016(%)

Have Any Query? Ask Our Experts @

Grand View Research has segmented the global cancer stem cells market on the basis of mode of action, cancer forms, and region:

Cancer Stem Cells Mode of Action Outlook (Revenue, USD Million, 2014 – 2025)

  • Targeted Cancerous Stem Cells (CSCs)
    • By Anti-Cancer Stem Cell Therapeutics
      • Pathway Inhibitors
        • WNT Signaling Pathway
        • Hedgehog Signaling Pathway
        • Notch Signaling Pathway
        • Others
      • Surface Marker-based
      • Immuno-evasion & Targeting Tumor Microenvironment
      • Nanoparticle-based Therapies
      • Others
    • By Products
      • Cell Culturing
      • Cell Separation
      • Cell Analysis
      • Molecular Analysis
      • Others
  • Stem Cell-based Cancer Therapy
    • Autologous Stem Cell Transplant
    • Allogeneic Stem Cell Transplant

Cancer Stem Cells Cancer Forms Outlook (Revenue, USD Million, 2014 – 2025)

  • Breast Cancer
  • Blood Cancer
  • Lung Cancer
  • Brain Cancer
  • Colorectal Cancer
  • Pancreatic Cancer
  • Bladder Cancer
  • Liver Cancer
  • Other Cancer

Cancer Stem Cells Regional Outlook (Revenue, USD Million, 2014 – 2025)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
  • Asia Pacific
    • China
    • Japan
  • Latin America
    • Brazil
  • Middle East & Africa
    • South Africa

Browse Related Report:

Live Cell Imaging Market:

Cancer Biomarker Market:

About Grand View Research

Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.

Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:201, Spear Street, 1100
City: San Francisco
State: California
Country: United States